BioData World Congress USA

Big data is like teenage sex: everyone talks about it, nobody really knows how to do it, and everyone thinks everyone else is doing it, so everyone claims they are doing it... (Dan Ariely, Duke University).

We introduce to you the most important event in Big Data and Genomics. We have developed an event with the one goal of driving precision medicine to the clinic in the most streamlined and effective way possible.

- Bringing together clinicians, big pharma, biotech institutions, policy makers, visionary academics and data leaders to facilitate partnerships and drive progress.
- Reviewing game changing innovation, roadblocks, and critical success factors in the practical application of big data.
- Understanding how big data is driving developments in personalised medicine.

Precision medicine is only attainable through bringing together the world principal decision makers involved in this multidisciplinary effort to one platform. This is why the world leading international institutions have partnered to make this a reality. These institutions include: The Wellcome Trust Sanger Institute, EMBL-EBI, Global Alliance for Genomics and Health, Babraham Institute, ABPI, Pharmacogenetics and Stratified Medicine Network, BIA, Pistoia Alliance, Cancer Research UK, The Farr Institute and the Francis Crick Institute.

Time: 8:00 am - 5:00 pm

Price:
Vendor Package: USD 1500
Pharma/Biotech Package: USD 900
Academic Package: USD 500

Speakers: Prof Jong Bhak Director Genome Korea in Ulsan National Institute of Science and Technology, Dr Hans Tomas Bjornsson Director of Epigenetic and Chromatin Clinic Assistant Professor of Pediatrics John Hopkins Medical Centre, Mr Philip Bourne Associate Director for Data Science National Institutes of Health, Mr John Cai Director Medical Informatics Celgene, Mr James Cai Head of Data Science F Hoffmann La Roche Inc, Ms Wendy Chung Herbert Irving Associate Professor of Pediatrics Columbia University, Dr George Church Professor of Genetics Harvard Medical School, Dr Charles Cox Head of Genetic Experiment Design and Delivery GlaxoSmithKline, Mr Philip De Jager Department Neurology Manager Harvard Medical School Partners Center for Genetics and Genomics, Chris Dwan Acting Director of Information Technology M.I.T. and Harvard, Mr Yaniv Erlich Principal Investigator and Whitehead Fellow Whitehead Institute for Biomedical Research, Prof Louis Fiore Executive Director Massachusetts Veterans Epidemiology Research and Information Center Professor of Medicine Boston University, Lyn Fitzgerald Senior Vice President U.S, Global Development at National Comprehensive Cancer Network, National Comprehensive Cancer Network, Mr Sandro Galea Dean and Professor Boston Universitys School of Public Health, Mr Michael Gaziano Principal investigator of MVP (Million Veteran Program) study Brigham and Women's, Prof Paul Glimcher New York University, Rachel Goldfedder Partner PrecisionFDA Community, Mr Ted Goldstein Vice President of Development Technologies Apple Computer University of California Santa Cruz, Dr Robert Green Professor Brigham and Women's Hospital and Harvard Medical School, Jason Hughes Director of Enterprise Research Applications The Pennsylvania Hospital of The University of Pennsylvania Health System, David Hunter Dean Harvard Medical School, Mr Justin H Johnson Associate Director and Principal Translational Genomic Scientist AstraZeneca, Mr Andreas Kogelnik President and Founder Open Medicine Institute, Dr Matthew Lebo Associate Professor of Pathology BWH and Harvard Medical School Director Partners Laboratory for Molecular Medicine Partners HealthCare System Inc., Mr David Ledbetter Executive Vice President and Chief Scientific Officer Geisinger Health System, Michaela Lorga Senior Security Technical Lead for Cloud Computing N.I.S.T., James Lowey Chief Information Officer Translational Genomics Research Institute (TGen), Assist. Prof Christopher Mason Assistant Professor in the Institute for Computational Biomedicine Cornell University, Chase Miller Director of Research and Science The University of Utah, Ms Kenna Mills Shaw Executive Director and Institute For Personalized Cancer Therapy M.D. Anderson Cancer Center, Assoc. Prof Matthew Nelson Head Genetics Gsk, Mr Robert Plenge Vice President and Head of Translational Medicine Merck and Co, Dr Mathew Pletcher Vice President Head of Genomic Discovery Autism Speaks, Mr Isaac Samuel Kohane Professor of Pediatrics and Health Sciences Technology Childrens Hospital and Harvard Medical School Countway Library of Medicine i2b2 National Center For Biomedical Computing H.M.S., Dr Giselle Sholler Chair NMTRC, Prof David Smith Professor of Laboratory Medicine and Pathology Chairman of the Technology Assessment Group Center for Individualized Medicine Mayo Clinic, Christopher Sprangel Director IT Human Genetics Regeneron Pharmaceuticals Inc, Prof Peter Tonellato Senior Research Scientist and Director of the Laboratory for Personalized Medicine Harvard Medical School, Mr Matthew Trunnell Vice President, CIO Fred Hutchinson Cancer Research Center, Mr Yirong Wang Associate Director of Production Bioinformatics Icahn School of Medicine at Mount Sinai, Juliet Williams Head of Oncology Pharmacology Novartis, Wendy Winckler Executive Director Next Generation Diagnostics Novartis, John Witte Chairman Naniq Systems Llc